Content uploaded by San Ming Wang
Author content
All content in this area was uploaded by San Ming Wang on May 19, 2015
Content may be subject to copyright.
Stable transcriptional status in the apoptotic erythroid genome
Sanggyu Lee
a,
*
, Junmo Hwang
a
, Jodie Ulaszek
b
, Yeong C. Kim
c
, Hui Dong
c
,
Hyung Soo Kim
a
, Ji Woong Seok
a
, Bo Kyung Suh
a
, So Jeong Yim
a
,
Debra Johnson
d
, Nong Hoon Choe
e
, Kyu Tae Chang
f
, Zae Young Ryoo
a
,
Charles C. Tseng
d
, Amittha Wickrema
b
, San Ming Wang
c,
*
a
School of Life Science and Biotechnology, Kyungpook National University, Daegu, Republic of Korea
b
Department of Medicine, University of Chicago, IL 60637, USA
c
Center for Functional Genomics, ENH Research Institute, Northwestern University, 1001 University Place, Evanston, IL 60201, USA
d
Department of Biological Sciences, Purdue University Calumet, Hammond, IN 46323, USA
e
College of Veterinary Medicine, Konkuk University, Seoul, Republic of Korea
f
National Primate Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea
Received 18 May 2007
Available online 4 June 2007
Abstract
When a cell is destined for apoptosis, will its genome reprogram its transcriptional machinery to overcome the life-threatening chal-
lenge? To address this issue, we performed a genome-wide transcriptome analysis in EPO (erythropoietin) deprivation-induced apoptotic
erythroid cells using the SAGE method. The results show that the transcript contents for the majority of the genes remain unchanged in
the apoptotic cells, including the apoptotic genes and the heat shock genes. Of the small number of genes with an altered expression, they
are mainly associated with cellular structure. Our study reveals that there is no genetic reprogramming for the transcriptional machinery
in the apoptotic genome. Apoptosis, as defined by programmed cell death, is not a crisis but a peaceful physiological process.
Ó 2007 Elsevier Inc. All rights reserved.
Keywords: Transcription; Gene expression; SAGE; Apoptosis; Erythroid; Genome
Apoptosis is an important biological process in main-
taining the proper progression during development and cel-
lular differentiation. With extensively analysis using
biochemical approaches, the general machinery of apopto-
sis has been elucidated with the identification of many
genes that are directly involved in apoptosis pathways. This
information provides a solid basis for our understanding of
apoptotic molecular machinery.
Besides the genes directly involved in the apoptosis
pathways, it is not clear that when a cell is destined for
apoptosis, will the apoptotic genome react drastically by
reprogramming its gene expression machinery to make a
large-scale change of gene expression? We investigated this
issue by analyzing the contents of the transcript in the
apoptotic erythroid cells. Erythroid differentiation starts
from the hematopoietic stem cells to the erythroid lineage
committed BFU-E, and goes through the stages of CFU-E,
pronormoblast, orthochromatophilic erythroblast, poly-
chromatophilic erythroblast, reticulocyte, and the mature
red blood cells [1]. Cytokines including EPO (erythropoie-
tin) play critical roles in initiating erythroid lineage com-
mitment and in driving erythroid differentiation [2–6].
Without EPO, erythroid cells rapidly undergo apoptosis
[7]. Our study focused on the analysis of the transcriptional
status in primary apoptotic erythroid cells to closely reflect
their physiological conditions. In this study, we used the
SAGE method for the analysis [8], in an aim to provide
quantitative measure for both known and unknown
transcripts.
0006-291X/$ - see front matter Ó 2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.bbrc.2007.05.168
*
Corresponding authors. Fax: +82 53 943 6925 (S. Lee), +1 224 364
5003 (S.M. Wang).
E-mail addresses: slee@knu.ac.kr (S. Lee), swang1@northwestern.edu
(S.M. Wang).
www.elsevier.com/locate/ybbrc
Biochemical and Biophysical Research Communications 359 (2007) 556–562
Materials and methods
Primary erythroid cell isolation and culture. Primary human erythroid
progenitor cells were generated from CD34
+
early hematopoietic cells as
previously described [9]. Briefly, CD34
+
uncommitted hematopoietic cells
were isolated from mobilized peripheral blood (All Cells, Berkeley, CA)
using the Isolex 300i cell selection device. Subsequently, CD34
+
cells were
cultured in IMDM containing 15% human AB serum, 15% fetal bovine
serum, erythropoietin (Epo), stem cell factor (SCF), and interleukin-3 (IL-
3). During subsequent feedings starting on day 3, no new IL-3 was added to
the cultures. On day 6 of being cultured (Late BFU-E/Early CFU-E), cells
were further purified by glycophorin A selection using paramagnetic beads
coated with anti-glycophorin A antibody (Miltenyi Biotec, Aurban, CA).
After selection, glycophorin A positive cells were re-cultured for 24 h in the
same culture media with growth factors. The cells were then washed
extensively with IMDM and cultured in two separate dishes: one in the
presence of Epo (2 U/ml) and the other in the absence of Epo in serum-
containing media. During the culture, cells were stained with benzidine and
hematoxylin, and analyzed by flow cytometry with annexin and propidium
iodide. Total RNA was isolated from cells with Trizolä reagent.
SAGE library construction and SAGE tag collection. SAGE libraries
were constructed following the SAGE protocol [10]. Briefly, total RNA
and mRNA were purified from the control cells and apoptotic cells.
Double-strand cDNA were synthesized, and 3
0
cDNA were purified using
NlaIII digestion. SAGE tags were released from 3
0
cDNA for cancate-
merization and cloning into the pZero vector. Sequencing reactions for
SAGE clones were performed with ABI Big-Dye 3.1 kit. Sequences were
collected using a Megabace DNA sequencer (Amersham, Piscataway, NJ).
Sequences passed Phred20 were used for SAGE tag extraction.
SAGE data analysis. SAGE tags were extracted from sequences using
SAGE 300 software. To identify the gene origins, SAGE tags were
matched to SAGEmap database (http://www.ncbi.nlm.nih.gov/SAGE/).
For the SAGE tags shared by multiple genes, the most likely gene for
these SAGE tags was identified through matching these SAGE tags to a
tissue-specific tag to the gene database under the tissue type ‘‘Blood’’
(http://basic.northwestern.edu). The Audic and Claverie method [11,12,
http://telethon.bio.unipd.it/bioinfo/IDEG6/] was used to identify the
statistically different SAGE tags between the control and apoptotic cells.
Two pre-conditions were set to determine the differentially expressed genes
in the control and apoptotic cells, including p values <0.05 and fold
Fig. 1. Induction of apoptosis in primary human erythroid progenitors deprived of growth factors. Primary erythroid progenitor cells were collected
beginning on day 7 of being cultured in the presence (A) or absence (B–D) of EPO for (B) 6 h, (C) 8 h, or (D) 24 h. The extent of apoptosis was determined
by a flow cytometry assay to ascertain the percentages of cells positive for annexin and propidium iodide.
S. Lee et al. / Biochemical and Biophysical Research Communications 359 (2007) 556–562 557
Table 1
Comparison between control and apoptotic cells
(A) Total SAGE tag comparison between the control and apoptotic cells
Control Apoptosis
Total tags 37,279 40,009
Unique tags 20,162 20,690
Total:unique 1.8:1 1.9:1
Match 12,154 (60) 12,558 (61)
Novel 8008 (40) 8132 (39)
(B) Quantitative distribution of SAGE tag between control and apoptotic cells
>50 49 to 10 9 to 5 4 to 2 1 Total
Tags matched to known genes
Apoptosis 50 250 419 2141 9698 12,558
Control 45 253 376 2151 9329 12,154
Tags without match to known genes
Apoptosis 6 27 71 599 7429 8132
Control 4 19 50 557 7378 8008
Table 2
Expression level of classical apoptotic genes in the apoptotic BFU-E cells
Gene UniGene ID SAGE tag
a
SAGE tag copy Fold change p value
Control Apoptosis
BAX Hs.159428 GGCATTTTTC 6 0 6.0 0.007
AAGACAGGGG 1 0 1.0 0.250
BAK1 Hs.93213 ACTCCCAAGG 0 1 1.0 0.268
BID Hs.300825 TCAACAGCGT 3 3 1.0 0.161
GCACAGAGAT 0 1 1.0 0.268
CTGGTGCTGG 0 1 1.0 0.268
GTCTCTTTGG 0 2 2.0 0.139
CASP2 Hs.433103 ATCCACCCAC 4 2 2.0 0.113
CASP8 Hs.243491 AACCTGCTGG 0 1 1.0 0.268
GGGAAACAGA 1 0 1.0 0.250
CASP9 Hs.329502 ATCCTGTGTT 0 1 1.0 0.268
GATCCCTGTG 1 1 1.0 0.258
CASP3 Hs.141125 GGCGTGTTCC 0 1 0.0 0.268
CASP6 Hs.3280 CCTGCAATCC 15 24 1.6 0.032
GAGAAGCCCC 3 1 3.0 0.120
GAAGATGCTG 0 1 1.0 0.268
CASP7 Hs.9216 CAAAAGTTCT 1 0 1.0 0.250
CYCS Hs.437060 TTCATTTGCC 3 2 1.5 0.156
FADD Hs.86131 TGAGGATTAT 1 0 1.0 0.250
CCACTCACCC 0 1 1.0 0.268
GGAAACTCTG 0 1 1.0 0.268
IKBKG Hs.43505 TGCAAGTTCC 1 0 1.0 0.250
NFKB1 Hs.160557 GACCCGGGGG 0 1 1.0 0.268
TTTGCTGCTG 1 0 1.0 0.250
ATTATGGGCA 1 0 1.0 0.250
RELA Hs.132594 CAACAGCACT 1 2 2.0 0.201
GAATTCCAGT 2 0 2.0 0.120
RIPK1 Hs.390758 AAGCTCTGCT 0 1 1.0 0.268
TNF
TNFSF10 Hs.387871 CCACTACACT 29 20 1.5 0.018
TNF Hs.241570 TAGCCCCCTG 0 1 1.0 0.268
TNF receptor
TNFRSF1A Hs.159 CCCGTTTTGG 0 1 1.0 0.268
GGCCTCTCCA 0 1 1.0 0.268
GGGCCTTCAG 0 1 1.0 0.268
TNFRSF1B Hs.256278 GTAAAACCCC 31 24 1.3 0.027
GGTGACTCAG 1 0 1.0 0.250
ATGGAGCGCA 0 3 3.0 0.072
GCCAGTGTGA 1 0 1.0 0.250
TRADD Hs.89862 AAGCACCTTG 1 0 1.0 0.250
a
Different SAGE tags for the same gene reflect the transcript isoforms expressed from the same gene.
558 S. Lee et al. / Biochemical and Biophysical Research Communications 359 (2007) 556–562
change P4. The Gene Ontology (GO) ‘‘Biological Process’’ term (http://
www.geneontology.org) was used to classify the alternatively expressed
genes in the apoptotic cells into functional categories.
Semi-quantitative PCR. A semi-quantitative PCR assay was used to
confirm the SAGE results. For each reaction, a set of sense and anti-
sense primers was designed based on the tag-matched sequences (Sup-
plementary Table 2). Total RNA samples from the control and
apoptotic cells were used as the templates for PCR. b-Actin was used as
the internal control. Amplicons were aliquoted and loaded on 2%
agarose gel for visualization.
Results and discussion
Erythroid progenitors rapidly progress to apoptosis upon Epo
deprivation
Several studies have been performed in addressing the
genome response to apoptosis [13,14]. These studies were
largely performed using transformed cell lines using
microarray-based approaches. Although the results are
informative, it can not be certain that the observation
will be the same in the primary cells. In addition, micro-
array-based approaches can only detect the known genes
or transcripts. It is not certain whether there are novel
genes or novel trans cripts present in the apoptotic cells.
In this study, we analyzed the apoptotic primary human
erythroid progenitors derived from normal hematopoietic
stem/progenitor cells, in an aim to provide the informa-
tion close to the primary cells. These cells, derived from
early-uncommitted CD34
+
hematopoietic stem/progeni-
tor cells, are absolutely dependent on Epo for growth.
Following Epo deprivation, cells rapidly undergo the
apoptotic stage (Fig. 1). Although the rate of apoptotic
cells is higher in longer time frame, the RNA in the
apoptotic cells becomes degraded. To obtain a balanced
level of apoptotic cells and good RNA quality for the
analysis, we used the cells after an 8-h EPO deprivation
that contained about 55% apoptotic cells. We used the
SAGE method to detect the transcripts in an aim to pro-
vide a quantitative measurement of gene expression, not
only for transcripts from known genes but also from
novel transcripts/novel genes.
Transcription status in the apoptotic erythroid genome
We collected 40,009 SAGE tags from the control
cells and 37,295 SAGE tags from the apoptotic cells.
From these SAGE tags, we identified 20,162 unique
SAGE tags for the control cells and 20,690 unique
SAGE tags for the apoptotic cells. We performed the
following analyses using the data from the control and
apoptotic cells.
We compared the ratio between the total tags and the
unique tags identified from the total tags. This ratio
reflected the general abundance of transcripts expressed
in the cells. A higher ratio indicated lower number of
expressed transcripts and vice versa. The ratio was similar
between the two sets of data, with 1.9:1 in the apoptotic
cells and 1.8:1 in the control cells. We compared the ratio
between the SAGE tags matched to known genes and the
novel SAGE tags without matches. This ratio was also sim-
ilar between the control cells and apoptotic cells, with 60%
matched tags and 40% novel tags in the control cells and
61% matched tags and 39% novel tags in the apoptotic cells
(Table 1A and Supple mentary Table 1). We further com-
pared the quantitative distribution of the matched SAGE
tags and novel SAGE tags between the control and
apoptotic cells. The distribution provided a measure for
large-scale quantitative changes of the known genes and
Fig. 2. Semi-quantitative RT-PCR confirmation. (A) Confirmation for
Bax gene expression. Specific sense and antisense primers for Bax
transcripts were designed. RNA samples extracted from cells in the
presence or absence of EPO were used as the templates for the analysis. (B)
12 SAGE tags that differed between the control and apoptotic cells were
chosen. Sense and antisense primers were designed using the SAGE tag-
matched sequences. Reactions No. 7 and 8 were negative (not shown).
b-Actin was used as the internal control for semi-quantitative PCR.
Amplicons at different PCR cycles were loaded on gels. See Supplementary
Table 2 for detailed information.
S. Lee et al. / Biochemical and Biophysical Research Communications 359 (2007) 556–562 559
Table 3
Heat shock gene expression between the control and apoptotic cells
Heat shock gene UniGene ID Common tag Different tags Tag copy
a
Control Apoptosis Control Apoptosis
Heat shock 27 kDa protein 1 Hs.76067 CCCAATCTAG 1 1
ACCCTCCCCT 1 n.d.
AGTGCCGGTG 1 n.d.
CCAAGCTTGG 1 n.d.
CCCAAGCTAG 1 n.d.
CCCCAAGCTA 1 n.d.
GCAACAACAG 1 n.d.
ATTGCAGCAC n.d. 3
TTCCCTCCCT n.d. 2
Heat shock 60 kDa protein 1 Hs.79037 TACCAGTGTA 12 3
TACCCAGTGT 2 n.d.
TTCTAACTCC 2 n.d.
AACTTTAGGG 1 n.d.
AAGACAGCTG 1 n.d.
TTACTGGACT 1 n.d.
Heat shock 70 kDa protein 1A Hs.75452 CGCTCGATCT 2 1
CAGAGATGAA 2 n.d.
Heat shock 70 kDa protein 5 Hs.310769 TGCATCTGGT 12 7
CAGGTGGTAG 1 n.d.
GAAACAGCTG 1 n.d.
GAACACTTCA 1 n.d.
AACCAAACTG n.d. 1
Heat shock 70 kDa protein 8 Hs.180414 CCAGGAGGAA 26 7
CAGGAGGAAT 1 n.d.
CCCAAGGTCC 1 n.d.
CTTGTGAACG 1 n.d.
GGATACTCAA 1 n.d.
TTCACACATT 1 n.d.
AACTCTCAAA n.d. 1
ACAAAAGGAT n.d. 1
AGCCAACTGC n.d. 1
GCTTAAATGT n.d. 1
TTGGTGATAC n.d. 1
Heat shock 70 kDa protein 9B Hs.184233 AGTGAAACCC 18 10
TTTGTAGATG 1 n.d.
AGCCCACCGG n.d. 1
GCACTTCAGA n.d. 1
GGCACTTTCC n.d. 1
Heat shock 90 kDa protein 1, a Hs.446579 GAAGCTTTGC 34 8
TACTAGTCCT 26 5
Heat shock 90 kDa protein 1, b Hs.74335 TGATTTCACT 54 76
GGCTCCCACT 25 10
ATTCAAGCTT 13 22
GTGAGCCCAT 15 6
GGCTCCACTG 2 n.d.
GGTGAAGCCC 2 n.d.
GTTGAGCCCA 2 n.d.
AAGCCCAGCA 1 n.d.
AGGCAGGATG 1 n.d.
ATCAAGTAGG 1 n.d.
AAAAGAAATC n.d. 1
ATTGGGCAGT n.d. 1
CCGAAACAGA n.d. 1
GAGAGGAGGA n.d. 1
GGCTCCCATT n.d. 1
Heat shock 105/110 kDa protein 1 Hs.36927 TGAACCCGTT 6 n.d.
TTGTTGACTA 1 n.d.
a
n.d., not detected.
560 S. Lee et al. / Biochemical and Biophysical Research Communications 359 (2007) 556–562
the novel transcripts in the apoptotic cells. The distribution
patterns showed no significant differences between the con-
trol and the apoptotic cells (Table 1B).
We then compared the genes detected in both the control
and apoptotic cells (Table 1B). There were 12,154 and
12,558 SAGE tags matc hed to known genes in the control
and apoptotic cells correspondingly. Comparing these two
sets of data showed that the 3718 matched tags were present
in both cell popul ations. This result indicated that the
majority of known genes expressed in both control and
the apoptotic cells were similar. We then compared the
novel SAGE tags shared between these two cell types. 949
novel SAGE tags were present in both cell types. The rate
was lower than the matched SAGE tags. This may relate
with several possibilities: the novel SAGE tags were mostly
at low copy numbers, representing the low abundant tran-
scripts. The present coverage of the SAGE tag collection
did not reach the saturated coverage of the transcripts,
but tended more to random detection that lead to lower
overlapping between the control and apoptotic cells. In
addition, there were certain portions of novel SAGE tags
that were related with sequencing errors. But the high rate
overlapping between the control and apoptotic cells implied
the constant gene expression between these two cell types.
We next compared the expression of the classical apop-
totic genes between the control and the apoptotic cells
(Table 2). Of these apoptotic genes, all except Bax gene
remained stably expressed in the apoptotic cells, such as
TNF, BID, and CASP 2 genes. The stable expression of
these apoptotic genes implied that there were no regulatory
changes for their expression in the apoptotic cells. Interest-
ingly, the BAX gene changed from six copies detected in
the control cells to unde r a detection level in the apoptotic
cells. This observation was confirmed by semi-quantitative
PCR (Fig. 2A). BAX is an important apoptosis regulator
that promotes apoptosis by releasing cytochrome c from
the mitochondrion. Expression of the BAX gene would
be expected to have increased in the apoptotic cell [15].
The unexpected turn-off of BAX gene expression in the
apoptotic cells might be because BAX transcripts are
needed at an earlier stage of apoptosis for protein synthe-
sis. After the initiation of apoptosis, the continued presence
of BAX transcripts may not be required. The unique
expression of the BAX gene provides a potential target
for intervention of erythroid apoptosis.
We analyzed the expression of classical heat shock genes
in the apoptotic cells. Heat shock genes are molecular
chaperones involved in maintaining the protein structures
for cells. When a cell is under external and internal stress
conditions, these genes will rapidly increa se their expres-
sion level to protect the cells. We compared the SAGE tags
that represented the major transcripts and the alternatively
spliced/adenylated isoforms of each heat sh ock genes.
Compared with those in the control cells, we saw no signs
Table 4
SAGE tags statistically different between the control and the apoptotic cells
(A) SAGE tags different between the control and apoptotic cells
Presence Absence Increase Decrease Total
Matched SAGE tags 73 59 44 68 244
Novel SAGE tags 24 10 14 5 53
Total 97 69 58 73 297
(B) Functional classification of genes alternatively expressed in the apoptotic cells
Functional categories Number of grouped genes
Decreased in the apoptotic cells
Biosynthesis 12
Carboxylic acid biosynthesis 3
Fatty acid biosynthesis 3
Nitric oxide biosynthesis 2
Organic acid biosynthesis 3
Ribonucleotide biosynthesis 3
Energy metabolism 5
Cell cycle and proliferation 10
Protein folding 6
Transport 14
Increased in the apoptotic cells
Actin cytoskeleton organization 4
Cell organization and biogenesis 9
Lipid metabolism 7
Macromolecule biosynthesis 8
Organelle organization and biogenesis 5
Regulation of cell cycle 6
Regulation of metabolism 14
Regulation of physiological process 14
S. Lee et al. / Biochemical and Biophysical Research Communications 359 (2007) 556–562 561
of increased expression of heat shock genes in the apoptotic
cells. In fact, several genes decreased their expression in the
apoptotic cells (Table 3). The stable expression of heat
shock genes implied that the apoptotic cells were not in
the state of stress.
The limited number of genes alternatively expressed in the
apoptotic genome
Although a large-scale alternation of gene expression
was not observed in the apoptotic cells, there were 297
SAGE tags statistically different between the apoptotic
cells and the control cells, representing 244 known genes
and 53 novel transcripts (Table 4A and Supplementary
Table 3). The differences were verified by semi-quantitative
RT-PCR for a group of the SAGE tags (Fig. 2B and Sup-
plementary Table 2). Using the Gene Ontology ‘‘biologic al
process’’ term, 128 of the known genes were grouped into
several functional categories. The genes that showed
decreased expression were large ly involved in biosynthesis
of smal l molecular blocks such as carboxylic acid, fatty
acid, organic acid, and ribonucleotides; the genes that
showed increased expression were mostly involved in
cellular organization (Table 4B and Supplemen tary
Table 4).
In summary, our study shows that there are no large-
scale alternations of gene expression in the apoptotic ery-
throid cells, including the apoptosis genes and heat shock
genes. The small numbers of alternated genes are related
with the synthes is of basic bio-block molecules and cellular
structure. Our study indicates that there is no genetic
reprogramming for gene expression in the apoptotic
erythroid genome. From the gene expression point of view,
apoptosis is not a crisis but a peaceful physiological pro-
cess, as precisely defined as ‘‘the programmed cell death’’.
Acknowledgments
The authors thank Dr. Janet D. Rowley for her support
for this project. This study was supported by the National
Institute of Heal th and the Daniel F., Ada L. Rice Founda-
tion (S.M.W.) and Kyungpook National University
Research Fund, 2005 (S.L.).
Appendix A. Supplementary data
Supplementary data associated with this article can be
found, in the online version, at doi:10.1016/j.bbrc.
2007.05.168.
References
[1] U. Testa, Apoptotic mechanisms in the control of erythropoiesis,
Leukemia 18 (2004) 1176–1199.
[2] S.B. Krantz, Erythropoietin, Blood 77 (1991) 419–434.
[3] M.J. Koury, S.T. Sawyer, S.J. Brandt, New insights into erythropoi-
esis, Curr. Opin. Hematol. 9 (2002) 93–100.
[4] L.L. Kelley, M.J. Koury, M.C. Bondurant, S.T. Koury, S.T. Sawyer,
A. Wickrema, Survival or death of individual proerythroblasts results
from differing erythropoietin sensitivities: a mechanism for controlled
rates of erythrocyte production, Blood 82 (1993) 2340–2353.
[5] K. Sawada, S.B. Krantz, S.T. Sawyer, C.I. Civin, Quantitation of
specific binding of erythropoietin to human erythroid colony forming
cells, J. Cell. Physiol. 137 (1988) 337–342.
[6] A. Wickrema, S.B. Krantz, M.C. Bondurant, Differentiation and
erythropoietin receptor gene expression in human erythroid progen-
itor cells, Blood 80 (1992) 1940–1949.
[7] S. Uddin, S. Kottegoda, D. Stigger, L.C. Platanias, A. Wickrema,
Activation of the Akt/FKHRL1 pathway mediates the antiapoptotic
effects of erythropoietin in primary human erythroid progenitors,
Biochem. Biophys. Res. Commun. 275 (2000) 16–19.
[8] V.E. Velculescu, L. Zhang, B. Vogelstein, K.W. Kinzler, Serial
analysis of gene expression, Science 270 (1995) 484–486.
[9] D.L. Mahmud, M.G. Amlak, D.K. Deb, L.C. Platanias, S. Uddin, A.
Wickrema, Phosphorylation of forkhead transcription factors by
erythropoietin and stem cell factor prevents acetylation and their
interaction with coactivator p300 in erythroid progenitor cells,
Oncogene 21 (2002) 1556–1562.
[10] S. Lee, J. Chen, G. Zhou, S.M. Wang, Generation of high quantity
and quality tag/ditag cDNAs for SAGE analysis, BioTechniques 31
(2001) 348–354.
[11] S. Audic, J.M. Claverie, The significance of digital gene expression
profiles, Genome Res. 7 (1997) 986–995.
[12] C. Romualdi, S. Bortoluzzi, F. D’Alessi, G.A. Danieli, IDEG6: a web
tool for detection of differentially expressed genes in multiple tag
sampling experiments, Physiol. Genomics 12 (2003) 159–162.
[13] M. Bjorling-Poulsen, O.G. Issinger, cDNA array analysis of altera-
tions in gene expression in the promyelocytic leukemia cell line,
HL-60, after apoptosis induction with etoposide, Apoptosis 8 (2003)
377–388.
[14] A. Brachat, B. Pierrat, A. Brungger, J. Heim, Comparative micro-
array analysis of gene expression during apoptosis-induction by
growth factor deprivation or protein kinase C inhibition, Oncogene
19 (2000) 5073–5082.
[15] T. Miyashita, J.C. Reed, Tumor suppressor p53 is a direct transcrip-
tional activator of the human bax gene, Cell 80 (1995) 293–299.
562 S. Lee et al. / Biochemical and Biophysical Research Communications 359 (2007) 556–562